cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
UVM	cis	rs12541595	0.928	rs72716972	MIMAT0019731	hsa-miR-4662a-5p	-8.41	2.85e-11	-0.76	-0.76	Left ventricle diastolic internal dimension;	chr8:124846279	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.93	rs55679363	MIMAT0019731	hsa-miR-4662a-5p	-8.38	3.2e-11	-0.73	-0.76	Left ventricle diastolic internal dimension;	chr8:124855592	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.93	rs35006907	MIMAT0019731	hsa-miR-4662a-5p	-8.34	3.72e-11	-0.73	-0.76	Left ventricle diastolic internal dimension;	chr8:124847575	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.93	rs34866937	MIMAT0019731	hsa-miR-4662a-5p	-8.34	3.72e-11	-0.73	-0.76	Left ventricle diastolic internal dimension;	chr8:124847608	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.93	rs7461129	MIMAT0019731	hsa-miR-4662a-5p	-8.34	3.72e-11	-0.73	-0.76	Left ventricle diastolic internal dimension;	chr8:124849132	chr8:124821990~124822011:+
UVM	cis	rs12541595	1	rs12541595	MIMAT0019731	hsa-miR-4662a-5p	8.34	3.73e-11	0.76	0.76	Left ventricle diastolic internal dimension;	chr8:124845117	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.787	rs12542527	MIMAT0019731	hsa-miR-4662a-5p	-7.78	2.85e-10	-0.72	-0.73	Left ventricle diastolic internal dimension;	chr8:124864202	chr8:124821990~124822011:+
UVM	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	7.64	4.66e-10	0.98	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	7.64	4.66e-10	0.98	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	7.64	4.66e-10	0.98	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	7.64	4.66e-10	0.98	0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-7.64	4.66e-10	-0.98	-0.73	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-7.35	1.38e-09	-1.05	-0.71	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-7.14	2.97e-09	-0.95	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-7.14	2.97e-09	-0.95	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
UVM	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-7.14	2.97e-09	-0.95	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-7.14	2.97e-09	-0.95	-0.7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
UVM	cis	rs12541595	0.79	rs28455756	MIMAT0019731	hsa-miR-4662a-5p	-6.92	6.61e-09	-0.75	-0.69	Left ventricle diastolic internal dimension;	chr8:124881909	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.897	rs6985130	MIMAT0019731	hsa-miR-4662a-5p	6.9	7.12e-09	0.69	0.69	Left ventricle diastolic internal dimension;	chr8:124838774	chr8:124821990~124822011:+
UVM	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-6.85	8.54e-09	-1.01	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-6.85	8.54e-09	-1.01	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
UVM	cis	rs12541595	0.866	rs10107090	MIMAT0019731	hsa-miR-4662a-5p	6.83	9.3e-09	0.68	0.69	Left ventricle diastolic internal dimension;	chr8:124837372	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.866	rs7003871	MIMAT0019731	hsa-miR-4662a-5p	6.82	9.7e-09	0.68	0.69	Left ventricle diastolic internal dimension;	chr8:124839268	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.836	rs6980636	MIMAT0019731	hsa-miR-4662a-5p	6.82	9.7e-09	0.68	0.69	Left ventricle diastolic internal dimension;	chr8:124840274	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.897	rs7001128	MIMAT0019731	hsa-miR-4662a-5p	6.82	9.7e-09	0.68	0.69	Left ventricle diastolic internal dimension;	chr8:124840288	chr8:124821990~124822011:+
UVM	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-6.81	9.87e-09	-0.96	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-6.81	9.87e-09	-0.96	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
UVM	cis	rs12541595	0.754	rs3935882	MIMAT0019731	hsa-miR-4662a-5p	6.55	2.55e-08	0.71	0.67	Left ventricle diastolic internal dimension;	chr8:124886015	chr8:124821990~124822011:+
UVM	cis	rs12541595	0.836	rs6980573	MIMAT0019731	hsa-miR-4662a-5p	6.11	1.27e-07	0.64	0.65	Left ventricle diastolic internal dimension;	chr8:124840111	chr8:124821990~124822011:+
UVM	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-6.05	1.62e-07	-0.96	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
UVM	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-6.05	1.62e-07	-0.96	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
UVM	cis	rs10198628	0.713	rs4669876	MIMAT0014988	hsa-miR-3125	-6	1.93e-07	-0.83	-0.64	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12778174	chr2:12737376~12737395:+
UVM	cis	rs12541595	0.808	rs10105974	MIMAT0019731	hsa-miR-4662a-5p	-5.91	2.7e-07	-0.64	-0.63	Left ventricle diastolic internal dimension;	chr8:124842273	chr8:124821990~124822011:+
UVM	cis	rs10198628	0.685	rs10198180	MIMAT0014988	hsa-miR-3125	5.89	2.86e-07	0.82	0.63	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12796064	chr2:12737376~12737395:+
UVM	cis	rs10198628	0.664	rs973977	MIMAT0014988	hsa-miR-3125	-5.86	3.24e-07	-0.84	-0.63	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12765364	chr2:12737376~12737395:+
UVM	cis	rs2762049	0.524	rs806344	MIMAT0004489	hsa-miR-16-1-3p	-5.76	4.53e-07	-0.62	-0.62	Aortic root size;	chr13:50283285	chr13:50048985~50049006:-
UVM	cis	rs2910162	0.865	rs6878034	MIMAT0004608	hsa-miR-146a-3p	5.59	8.42e-07	0.85	0.61	Allergic disease (asthma, hay fever or eczema);	chr5:160488114	chr5:160485408~160485429:+
UVM	cis	rs2910162	0.865	rs4921142	MIMAT0004608	hsa-miR-146a-3p	5.59	8.42e-07	0.85	0.61	Allergic disease (asthma, hay fever or eczema);	chr5:160490208	chr5:160485408~160485429:+
UVM	cis	rs2910162	0.865	rs5010836	MIMAT0004608	hsa-miR-146a-3p	5.59	8.42e-07	0.85	0.61	Allergic disease (asthma, hay fever or eczema);	chr5:160492159	chr5:160485408~160485429:+
UVM	cis	rs2910162	0.865	rs4921291	MIMAT0004608	hsa-miR-146a-3p	5.59	8.42e-07	0.85	0.61	Allergic disease (asthma, hay fever or eczema);	chr5:160493288	chr5:160485408~160485429:+
UVM	cis	rs10198628	0.597	rs7592318	MIMAT0014988	hsa-miR-3125	-5.58	8.74e-07	-0.78	-0.61	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12785023	chr2:12737376~12737395:+
UVM	cis	rs10198628	0.536	rs6750735	MIMAT0014988	hsa-miR-3125	-5.58	8.74e-07	-0.78	-0.61	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12786497	chr2:12737376~12737395:+
UVM	cis	rs10198628	0.63	rs4669872	MIMAT0014988	hsa-miR-3125	-5.54	1.03e-06	-0.82	-0.61	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12761356	chr2:12737376~12737395:+
UVM	cis	rs10198628	0.555	rs10191751	MIMAT0014988	hsa-miR-3125	5.48	1.26e-06	0.75	0.6	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12822189	chr2:12737376~12737395:+
UVM	cis	rs10198628	0.625	rs10200527	MIMAT0014988	hsa-miR-3125	-5.46	1.35e-06	-0.77	-0.6	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12793791	chr2:12737376~12737395:+
UVM	cis	rs2113818	0.597	rs2059428	MIMAT0014988	hsa-miR-3125	-5.37	1.87e-06	-0.76	-0.6	Optic cup area;	chr2:12752803	chr2:12737376~12737395:+
UVM	cis	rs2910162	1	rs888656	MIMAT0004608	hsa-miR-146a-3p	-5.31	2.27e-06	-0.84	-0.59	Allergic disease (asthma, hay fever or eczema);	chr5:160476863	chr5:160485408~160485429:+
UVM	cis	rs2910162	1	rs2910162	MIMAT0004608	hsa-miR-146a-3p	-5.25	2.85e-06	-0.84	-0.59	Allergic disease (asthma, hay fever or eczema);	chr5:160482338	chr5:160485408~160485429:+
UVM	cis	rs2910162	1	rs2961919	MIMAT0004608	hsa-miR-146a-3p	-5.2	3.42e-06	-0.83	-0.58	Allergic disease (asthma, hay fever or eczema);	chr5:160476127	chr5:160485408~160485429:+
UVM	cis	rs11126435	0.8	rs6546914	MIMAT0021020	hsa-miR-5000-3p	-5.16	3.95e-06	-0.78	-0.58	Age-related hearing impairment (SNP x SNP interaction);	chr2:74608406	chr2:75090873~75090894:+
UVM	cis	rs13326165	0.76	rs11714402	MIMAT0004584	hsa-let-7g-3p	-5.15	4.01e-06	-0.44	-0.58	HDL cholesterol;HDL cholesterol levels;	chr3:52357719	chr3:52268280~52268300:-
UVM	cis	rs10198628	0.685	rs6727552	MIMAT0014988	hsa-miR-3125	4.89	1.01e-05	0.75	0.56	Pericardial fat;Pericardial adipose tissue adjusted for height and weight;	chr2:12792181	chr2:12737376~12737395:+
UVM	cis	rs11126435	0.8	rs6546917	MIMAT0021020	hsa-miR-5000-3p	-4.87	1.09e-05	-0.78	-0.56	Age-related hearing impairment (SNP x SNP interaction);	chr2:74646254	chr2:75090873~75090894:+
UVM	cis	rs10455248	0.567	rs7755374	MIMAT0000087	hsa-miR-30a-5p	4.86	1.11e-05	0.27	0.56	Cognitive performance;	chr6:71880827	chr6:71403595~71403616:-
UVM	cis	rs11126435	0.858	rs3179673	MIMAT0021020	hsa-miR-5000-3p	-4.81	1.35e-05	-0.76	-0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74557921	chr2:75090873~75090894:+
UVM	cis	rs11126435	0.8	rs752070	MIMAT0021020	hsa-miR-5000-3p	-4.81	1.35e-05	-0.76	-0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74597843	chr2:75090873~75090894:+
UVM	cis	rs11126435	0.8	rs28781876	MIMAT0021020	hsa-miR-5000-3p	-4.81	1.35e-05	-0.76	-0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74609143	chr2:75090873~75090894:+
UVM	cis	rs11126435	1	rs11126435	MIMAT0021020	hsa-miR-5000-3p	4.81	1.35e-05	0.76	0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74562573	chr2:75090873~75090894:+
UVM	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	4.74	1.71e-05	0.96	0.55	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
UVM	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	4.74	1.71e-05	0.96	0.55	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
UVM	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	4.74	1.72e-05	0.96	0.55	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
UVM	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-4.74	1.72e-05	-0.96	-0.55	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
UVM	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-4.74	1.72e-05	-0.96	-0.55	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
UVM	cis	rs11126435	0.72	rs2021725	MIMAT0021020	hsa-miR-5000-3p	-4.73	1.78e-05	-0.76	-0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74575090	chr2:75090873~75090894:+
UVM	cis	rs11126435	0.858	rs3025991	MIMAT0021020	hsa-miR-5000-3p	-4.72	1.79e-05	-0.65	-0.55	Age-related hearing impairment (SNP x SNP interaction);	chr2:74672680	chr2:75090873~75090894:+
UVM	cis	rs9662615	0.571	rs4653394	MIMAT0017981	hsa-miR-3605-5p	-4.68	2.12e-05	-0.51	-0.54	Response to lithium treatment in bipolar disorder;	chr1:34135775	chr1:33332449~33332471:-
UVM	cis	rs9662615	0.571	rs9425999	MIMAT0017981	hsa-miR-3605-5p	-4.59	2.84e-05	-0.5	-0.54	Response to lithium treatment in bipolar disorder;	chr1:34136920	chr1:33332449~33332471:-
UVM	cis	rs9662615	0.571	rs9426001	MIMAT0017981	hsa-miR-3605-5p	-4.59	2.84e-05	-0.5	-0.54	Response to lithium treatment in bipolar disorder;	chr1:34137225	chr1:33332449~33332471:-